T Cell and Innate Subsets in Chronic Immune Mediated Diseases

Thursday, June 15
8:30 AM - 9:00 AM

Learning Objectives:

Vijay K. Kuchroo

Samuel Wasserstrom Professor of Neurology
Harvard Medical School, Brigham & Women's Hospital

Dr. Vijay Kuchroo is the Samuel L. Wasserstrom Professor of Neurology at Harvard Medical School. Vijay Kuchroo is also an associate member of the Broad Institute and a participant in a Klarman Cell Observatory project that focuses on T cell differentiation. He was just named the Director of the newly formed Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women’s Hospital. His major research interests include autoimmune diseases and cancer. Dr. Kuchroo first described the inhibitory receptor TIM-3, which is being exploited as a target for cancer immunotherapy. He was aslo first to describe the development of highly pathogenic Th17 cells. He has published over 325 original research papers in the filed of Immunology and a paper describing development of Th17 authored by Dr. Kuchroo has been one of the highest cited papers in Immunology.

He obtained his degree in Veterinary Medicine from India and subsequently he specialized in pathology at the University of Queensland, Brisbane (Australia) where he obtained a Ph.D. in 1985. He received the Fred Z. Eager Research prize and medal for his Ph.D. research work at the University of Queensland. Based on his contributions, he was awarded the Javits Neuroscience Award by the National Institutes of Health in 2002 and the Ranbaxy prize in Medical Research from the Ranbaxy Science Foundation in 2011. He was named Distinguished Eberly lecturer in 2014 and obtained Nobel Laureate Peter Doherty lecture/prize in 2014.


Send Email for Vijay Kuchroo


T Cell and Innate Subsets in Chronic Immune Mediated Diseases

Attendees who have favorited this

Send Email for T Cell and Innate Subsets in Chronic Immune Mediated Diseases